Henri Wichmann
Ernst Grube Str, 40 06097
Halle, NI 06097, Germany
Halle, NI 06097, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Evaluation of the Betulinic Acid-Cisplatin conjugate APC and its precursor DE9B for the treatment of human malignant glioma.
Journal: Chemico-biological interactions
Published: June 04, 2019
Prediction of regulatory targets of alternative isoforms of the epidermal growth factor receptor in a glioblastoma cell line.
Journal: BMC bioinformatics
Published: February 06, 2019
Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients.
Journal: BMC cancer
Published: February 28, 2018
Cellular and radiobiological effects of carbonic anhydrase IX in human breast cancer cells.
Journal: Oncology reports
Published: November 05, 2017
Inhibition of Carbonic Anhydrase IX by Ureidosulfonamide Inhibitor U104 Reduces Prostate Cancer Cell Growth, But Does Not Modulate Daunorubicin or Cisplatin Cytotoxicity.
Journal: Oncology research
Published: June 21, 2017
P4HA1: A single-gene surrogate of hypoxia signatures in oral squamous cell carcinoma patients.
Journal: Clinical and translational radiation oncology
Published: May 15, 2017
Normoxic accumulation of HIF1α is associated with glutaminolysis.
Journal: Clinical oral investigations
Published: December 08, 2015
IDH1(R132H) mutation causes a less aggressive phenotype and radiosensitizes human malignant glioma cells independent of the oxygenation status.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: July 05, 2015
Betulinyl Sulfamates as Anticancer Agents and Radiosensitizers in Human Breast Cancer Cells.
Journal: International journal of molecular sciences
Published: May 06, 2015
mRNA expression levels of hypoxia-induced and stem cell-associated genes in human glioblastoma.
Journal: Oncology reports
Published: February 16, 2015
Betulinic acid derivatives NVX-207 and B10 for treatment of glioblastoma--an in vitro study of cytotoxicity and radiosensitization.
Journal: International journal of molecular sciences
Published: May 27, 2014
Targeting of EGFR and HER2 with therapeutic antibodies and siRNA: a comparative study in glioblastoma cells.
Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Published: May 13, 2014
Last Updated: 09/26/2026